Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges

References

• OtónT, CarmonaL. The epidemiology of established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2019;33(5):101477. doi:10.1016/j.berh.2019.10147731987685
   PubMed Web of Science ®Google Scholar
• GoldringSR. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol. 2002;14(4):406–410. doi:10.1097/00002281-200207000-0001312118176
   PubMed Web of Science ®Google Scholar
• SubesingheS, BechmanK, RutherfordAI, GoldblattD, GallowayJB. A systematic review and metaanalysis of antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis. J Rheumatol. 2018;45(6):733–744. doi:10.3899/jrheum.17071029545454
   PubMed Web of Science ®Google Scholar
• El-GabalawyH. The preclinical stages of RA: lessons from human studies and animal models. Best Pract Res Clin Rheumatol. 2009;23(1):49–58. doi:10.1016/j.berh.2008.11.00419233045
   PubMedGoogle Scholar
• ChangNC. Autophagy and stem cells: self-eating for self-renewal. Front Cell Develop Biol. 2020;8:138. doi:10.3389/fcell.2020.00138
   PubMed Web of Science ®Google Scholar
• RossCL, AngDC, Almeida-PoradaG. Targeting mesenchymal stromal cells/pericytes (MSCs) with Pulsed Electromagnetic Field (PEMF) has the potential to treat rheumatoid arthritis. Front Immunol. 2019;10:266. doi:10.3389/fimmu.2019.0026630886614
   PubMed Web of Science ®Google Scholar
• WangL, HuangS, LiS, et al. Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: a prospective phase I/Ii study. Drug Des Devel Ther. 2019;13:4331–4340. doi:10.2147/DDDT.S225613
   PubMed Web of Science ®Google Scholar
• WangL, WangL, CongX, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(23):3192–3202.23941289
   PubMed Web of Science ®Google Scholar
• Lopez-SantallaM, Fernandez-PerezR, GarinMI. Mesenchymal stem/stromal cells for rheumatoid arthritis treatment: an update on clinical applications. Cells. 2020;9(8):1852. doi:10.3390/cells9081852
   PubMed Web of Science ®Google Scholar
• CoelhoA, AlvitesRD, BranquinhoMV, GuerreiroSG, MaurícioAC. Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research. Front Cell Develop Biol. 2020;8:602647. doi:10.3389/fcell.2020.602647
   PubMed Web of Science ®Google Scholar
• WangL, HuangS, DangY, et al. Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report. Medicine. 2014;93(28):e340. doi:10.1097/MD.000000000000034025526496
   PubMed Web of Science ®Google Scholar
• WieneckeT, GøtzschePCJ. Paracetamol versus nonsteroidal anti‐inflammatory drugs for rheumatoid arthritis. Cochrane Database Syst Rev. 2004;(1):CD003789. doi:10.1002/14651858.CD003789.pub2.
   PubMedGoogle Scholar
• TianoHF, LoftinCD, AkundaJ, et al. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res. 2002;62(12):3395–3401.12067981
   PubMed Web of Science ®Google Scholar
• LovellDJ, RupertoN, GoodmanS, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med. 2008;359(8):810–820.18716298
   PubMed Web of Science ®Google Scholar
• SchettG, EmeryP, TanakaY, et al. Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Ann Rheum Dis. 2016;75(8):1428–1437.27261493
   PubMed Web of Science ®Google Scholar
• CastilloJ, MilaniC, Mendez-AllwoodDJE. Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders. Expert Opin Investig Drugs. 2009;18(4):491–500.
   PubMed Web of Science ®Google Scholar
• SongS-NJ, IwahashiM, TomosugiN, et al. Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. Arthritis Res Ther. 2013;15(5):1–10.
   Web of Science ®Google Scholar
• DowneyCJ. Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: a literature review. J Rheum Dis. 2016;19(6):536–550.
   Google Scholar
• SmolenJS, Van Der HeijdeDM, St. ClairEW, et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum. 2006;54(3):702–710.16508926
   PubMed Web of Science ®Google Scholar
• St. ClairEW, Van Der HeijdeDM, SmolenJS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum2004;50(11):3432–3443.15529377
   PubMed Web of Science ®Google Scholar
• BarteldsGM, WijbrandtsCA, NurmohamedMT, et al. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann Rheum Dis. 2007;66(7):921–926.17301106
   PubMed Web of Science ®Google Scholar
• RaaschouP, SimardJF, HolmqvistM, AsklingJ. Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden. BMJ. 2013;346(f1939).
   PubMedGoogle Scholar
• VizosoFJ, EiroN, CostaL, et al. Mesenchymal stem cells in homeostasis and systemic diseases: hypothesis, evidences, and therapeutic opportunities. Int J Mol Sci. 2019;20(15):3738. doi:10.3390/ijms20153738
   PubMed Web of Science ®Google Scholar
• ChenL, QuJ, XiangC. The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine. Stem Cell Res Ther. 2019;10(1). doi:10.1186/s13287-018-1105-9
   Web of Science ®Google Scholar
• LiY, JinD, XieW, et al. Mesenchymal stem cells-derived exosomes: a possible therapeutic strategy for osteoporosis. Curr Stem Cell Res Ther. 2018;13(5):362–368. doi:10.2174/1574888X1366618040316345629623851
   PubMed Web of Science ®Google Scholar
• QuJ, ZhangH. Roles of mesenchymal stem cells in spinal cord injury. Stem Cells Int. 2017;2017:5251313. doi:10.1155/2017/525131328630630
   PubMed Web of Science ®Google Scholar
• ZhouT, LiH-Y, LiaoC, LinW, LinS. Clinical efficacy and safety of mesenchymal stem cells for systemic lupus erythematosus. Stem Cells Int. 2020;2020:6518508. doi:10.1155/2020/651850832322279
   PubMed Web of Science ®Google Scholar
• FerroF, ElefanteE, LucianoN, TalaricoR, TodoertiM. One year in review 2017: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2017;35(5):721–734.28956527
   PubMed Web of Science ®Google Scholar
• SilvagniE, Di BattistaM, BonifacioAF, ZucchiD, GovernatoG, ScirèCA. One year in review 2019: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2019;37(4):519–534.31140394
   PubMed Web of Science ®Google Scholar
• CheungTT, McInnesIB. Future therapeutic targets in rheumatoid arthritis?Semin Immunopathol. 2017;39(4):487–500. doi:10.1007/s00281-017-0623-328451787
   PubMed Web of Science ®Google Scholar
• LuoY, WuW, GuJ, et al. Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis. EBioMedicine. 2019;43:620–631. doi:10.1016/j.ebiom.2019.04.05831076346
   PubMed Web of Science ®Google Scholar
• Luque-CamposN, Contreras-LópezRA, Jose Paredes-MartínezM, et al. Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Front Immunol. 2019;10:798. doi:10.3389/fimmu.2019.0079831040848
   PubMed Web of Science ®Google Scholar
• LiuR, ZhaoP, TanW, ZhangM. Cell therapies for refractory rheumatoid arthritis. Clin Exp Rheumatol. 2018;36(5):911–919.29745893
   PubMed Web of Science ®Google Scholar
• HaikalSM, AbdeltawabNF, RashedLA, Abd El-GalilTI, ElmaltHA, AminMA. Combination therapy of mesenchymal stromal cells and interleukin-4 attenuates rheumatoid arthritis in a collagen-induced murine model. Cells. 2019;8(8):823. doi:10.3390/cells8080823
   PubMed Web of Science ®Google Scholar
• LiE, ZhangZ, JiangB, YanL, ParkJW, XuRH. Generation of mesenchymal stem cells from human embryonic stem cells in a complete serum-free condition. Int J Biol Sci. 2018;14(13):1901–1909. doi:10.7150/ijbs.2530630443193
   PubMed Web of Science ®Google Scholar
• HynesK, BrightR, ProudmanS, HaynesD, GronthosS, BartoldM. Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: a systematic review. Semin Arthritis Rheum. 2016;46(1):1–19. doi:10.1016/j.semarthrit.2016.02.00827105756
   PubMed Web of Science ®Google Scholar
• AndrzejewskaA, LukomskaB, JanowskiM. Concise review: mesenchymal stem cells: from roots to boost. Stem Cells. 2019;37(7):855–864. doi:10.1002/stem.301630977255
   PubMed Web of Science ®Google Scholar
• LiuY, MuR, WangS, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther. 2010;12(6):R210. doi:10.1186/ar318721080925
   PubMed Web of Science ®Google Scholar
• BerglundAK, FisherMB, CameronKA, PooleEJ, SchnabelLV. Transforming growth factor-β2 downregulates Major Histocompatibility Complex (MHC) I and MHC II surface expression on equine bone marrow-derived mesenchymal stem cells without altering other phenotypic cell surface markers. Front Vet Sci. 2017;4:84. doi:10.3389/fvets.2017.0008428660198
   PubMed Web of Science ®Google Scholar
• KarahuseyinogluS, CinarO, KilicE, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells. 2007;25(2):319–331. doi:10.1634/stemcells.2006-028617053211
   PubMed Web of Science ®Google Scholar
• WangQ, LiX, LuoJ, et al. The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system. BMC Musculoskelet Disord. 2012;13(1):249. doi:10.1186/1471-2474-13-24923237239
   PubMed Web of Science ®Google Scholar
• GuJ, LinCM, GuW, et al. [Immunomodulatory effect of UC-MSC on function of immunocytes of rats with collagen type II induced arthritis]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22(1):166–170. [ Chinese]24598671
   PubMedGoogle Scholar
• ZhaoQ, RenH, HanZ. Mesenchymal stem cells: immunomodulatory capability and clinical potential in immune diseases. J Cell Immunother. 2016;2(1):3–20. doi:10.1016/j.jocit.2014.12.001
   Google Scholar
• ShouK, HuangY, QiB, et al. Induction of mesenchymal stem cell differentiation in the absence of soluble inducer for cutaneous wound regeneration by a chitin nanofiber-based hydrogel. J Tissue Eng Regen Med. 2018;12(2):e867–e880. doi:10.1002/term.240028079980
   PubMed Web of Science ®Google Scholar
• FuX, LiuG, HalimA, JuY, LuoQ, SongAG. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8(8):784.
   PubMed Web of Science ®Google Scholar
• ChenL, CarltonM, ChenX, et al. Effect of fibronectin, FGF-2, and BMP4 in the stemness maintenance of BMSCs and the metabolic and proteomic cues involved. Stem Cell Res Ther. 2021;12(1):165. doi:10.1186/s13287-021-02227-733676544
   PubMed Web of Science ®Google Scholar
• XuL, LiuY, SunY, et al. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther. 2017;8(1):275. doi:10.1186/s13287-017-0716-x29208029
   PubMed Web of Science ®Google Scholar
• ZhangB, LuoQ, HalimA, JuY, MoritaY, SongG. Directed differentiation and paracrine mechanisms of mesenchymal stem cells: potential implications for tendon repair and regeneration. Curr Stem Cell Res Ther. 2017;12(6):447–454. doi:10.2174/1574888X1266617050210242328464787
   PubMed Web of Science ®Google Scholar
• SongH, YinZ, WuT, et al. Enhanced effect of tendon stem/progenitor cells combined with tendon-derived decellularized extracellular matrix on tendon regeneration. Cell Transplant. 2018;27(11):1634–1643. doi:10.1177/096368971880538330298746
   PubMed Web of Science ®Google Scholar
• WuY, WangJ, ScottPG, TredgetEE. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007;15(Suppl s1):S18–26. doi:10.1111/j.1524-475X.2007.00221.x17727462
   PubMed Web of Science ®Google Scholar
• HerdrichBJ, LindRC, LiechtyKW. Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds. Cytotherapy. 2008;10(6):543–550. doi:10.1080/1465324080234582018836914
   PubMed Web of Science ®Google Scholar
• ChaJ, FalangaV. Stem cells in cutaneous wound healing. Clin Dermatol. 2007;25(1):73–78. doi:10.1016/j.clindermatol.2006.10.00217276204
   PubMed Web of Science ®Google Scholar
• FuX, LiH. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions. Cell Tissue Res. 2009;335(2):317–321. doi:10.1007/s00441-008-0724-319034523
   PubMed Web of Science ®Google Scholar
• SuhW, KimKL, KimJM, et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells. 2005;23(10):1571–1578. doi:10.1634/stemcells.2004-034016081667
   PubMed Web of Science ®Google Scholar
• VolkSW, RaduA, ZhangL, LiechtyKW. Stromal progenitor cell therapy corrects the wound-healing defect in the ischemic rabbit ear model of chronic wound repair. Wound Repair Regen. 2007;15(5):736–747. doi:10.1111/j.1524-475X.2007.00277.x17971020
   PubMed Web of Science ®Google Scholar
• WeiZ, YuanJ, WangG, OcanseyDKW, XuZ, MaoFJSCI. Regulatory effect of mesenchymal stem cells on t cell phenotypes in autoimmune diseases. Stem Cell Int. 2021;2021:5583994. doi:10.1155/2021/5583994
   Web of Science ®Google Scholar
• MattarP, BiebackK. Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Front Immunol. 2015;6:560.26579133
   PubMed Web of Science ®Google Scholar
• SongJ-Y, KangHJ, HongJS, et al. Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep. 2017;7(1):1–11.28127051
   PubMed Web of Science ®Google Scholar
• GreishS, AbogreshaN, Abdel-HadyZ, ZakariaE, GhalyM, HefnyM. Human umbilical cord mesenchymal stem cells as treatment of adjuvant rheumatoid arthritis in a rat model. World J Stem Cells. 2012;4(10):101–109. doi:10.4252/wjsc.v4.i10.10123189211
   PubMedGoogle Scholar
• ParkEH, LimHS, LeeS, et al. Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase Ia clinical trial. Stem Cells Transl Med. 2018;7(9):636–642. doi:10.1002/sctm.18-003130112846
   PubMed Web of Science ®Google Scholar
• QiT, GaoH, DangY, HuangS, PengM. Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis. Medicine. 2020;99(28):e21222. doi:10.1097/MD.000000000002122232664175
   PubMed Web of Science ®Google Scholar
• AugelloA, TassoR, NegriniSM, CanceddaR, PennesiG. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 2007;56(4):1175–1186. doi:10.1002/art.2251117393437
   PubMed Web of Science ®Google Scholar
• SensebéL, TarteK, GalipeauJ, et al. Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell. 2012;10(1):9–10. doi:10.1016/j.stem.2011.12.00522226349
   PubMed Web of Science ®Google Scholar
• StultzBG, McGinnisK, ThompsonEE, Lo SurdoJL, BauerSR, HurshDA. Chromosomal stability of mesenchymal stromal cells during in vitro culture. Cytotherapy. 2016;18(3):336–343. doi:10.1016/j.jcyt.2015.11.01726780865
   PubMed Web of Science ®Google Scholar
• DuarteDM, CornélioDA, CoradoC, et al. Chromosomal characterization of cryopreserved mesenchymal stem cells from the human subendothelium umbilical cord vein. Regen Med. 2012;7(2):147–157. doi:10.2217/rme.11.11322397605
   PubMed Web of Science ®Google Scholar
• ZhengG, LiuY, JingQ, ZhangL. Differentiation of human umbilical cord-derived mesenchymal stem cells into hepatocytes in vitro. Biomed Mater Eng. 2015;25(1 Suppl):145–157. doi:10.3233/BME-14124925538065
   PubMed Web of Science ®Google Scholar